IL-6上调SCD1表达对HepG2细胞脂质合成功能的影响*

doi:10.3969/j.issn.1672-5069.2019.02.005

实用肝脏病杂志 ›› 2019, Vol. 22 ›› Issue (2): 172-175.doi: 10.3969/j.issn.1672-5069.2019.02.005

IL-6上调SCD1表达对HepG2细胞脂质合成功能的影响^*

曹白鸽,刘冲霄,陈源文,董艳

200092 上海市上海交通大学医学院附属新华医院内分泌科（曹白鸽,刘冲霄,董艳）;
消化内科（陈源文）;
上海市儿科医学研究所（董艳）

收稿日期:2018-08-31 出版日期:2019-03-10 发布日期:2019-03-19
通讯作者: 董艳,E-mail: dongyansh@sjtu.edu.cn
作者简介:曹白鸽,女,24岁,硕士研究生。主要从事炎症与非酒精性脂肪性肝病发生机制研究。E-mail:caobaige158@163.com
基金资助:
* 上海市科委科研基金资助项目（编号：18ZR1431100）

Upregulation of SCD1 gene-related lipid synthesis by IL-6 stimulus in HepG2 cells in vitro

Cao Baige, Liu Chongxiao, Chen Yuanwen, Dong Yan

Department of Endocrinology,Xinhua Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200092,China

Received:2018-08-31 Online:2019-03-10 Published:2019-03-19

摘要/Abstract

摘要： 目的探讨IL-6对HepG2细胞硬脂酰辅酶A去饱和酶1 （SCD1）基因的影响及其SCD1基因表达的改变对细胞脂质合成的影响。方法应用rIL-6刺激HepG2细胞,检测细胞内脂质合成以及细胞SCD1基因水平变化。分别构建人SCD1真核表达质粒和小干扰（small interfering） RNA,转染HepG2细胞,观察改变SCD1水平后HepG2细胞脂代谢相关基因表达的变化以及细胞内脂质合成的变化。结果 rIL-6刺激HepG2细胞甘油三酯水平显著高于对照组（P<0.05）;与空质粒组比,转染真核表达质粒细胞SCD1 蛋白表达增加,细胞脂质合成相关基因SREBP1c和FASN相对水平增加1.35倍和1.27倍,脂质氧化代谢相关基因PPARα和ASCL3水平降低12.3%和13.5%;细胞甘油三酯水平显著升高（P<0.01）,而转染small interfering RNA,再用rIL-6刺激HepG2细胞SCD1蛋白表达显著降低,细胞甘油三酯水平也显著降低（P<0.05）,脂质合成相关基因SREBP1c和FASN水平显著下降了32.3%和51.9%,脂质分解相关基因PPARα相对水平也下降了80%（P<0.05）,而ASCL3水平无显著变化（P=0.832）。结论 rIL-6通过上调HepG2细胞SCD1基因表达,引起细胞内脂质合成增加,导致甘油三酯含量增多。

关键词: HepG2细胞, 硬脂酰辅酶A去饱和酶1, 脂质合成

Abstract: Objective To investigate the upregulation of stearoyl-CoA desaturase 1（SCD1）-related lipid synthesis by IL-6 stimulus in HepG2 cells in vitro. Methods HepG2 cells were stimulated by rIL-6,and the lipid accumulation and SCD1 levels were evaluated. The SCD1 eukaryotic plasmid and small interfering RNA were conducted and transfected into HepG2 cells,respectively,and the lipid metabolism-related genes and intracellular triglyceride contents were detected. Results The intracellular triglyceride content in rIL-6-stimulated cells was significantly higher than in control group（P<0.05）;the SCD1 gene increased by 1.36 folds compared with in the control （P<0.01） and the SCD1 protein increased at the same time;the upregulation of intracellular lipid synthesis-related SREBP1c and FASN also increased by 1.35 and 1.27 folds,respectively,and the downregulation of lipid oxidation-related PPARα and ASCL3 decreased by 12.3% and 13.5%,respectively;In addition,the SCD1 transfection increased intracellular TG content in HepG2 cells（P<0.01） as compared to that in vector transfected group;conversely,after transfection with small interfering RNA and stimulation by rIL-6,the SCD1 was reduced compared with in the negative control, the intracellular TG content significantly decreased（P<0.05） and the lipid synthesis-related SREBP1c and FASN decreased by 32.3% and 51.9%, while the lipid oxidation-related PPARα also decreased by 80% （P<0.05） with the ASCL3 gene not significantly changed （P=0.832）. Conclusion rIL-6 stimulation might induce lipid synthesis and increase the triglyceride content by upregulating SCD1 expression in HepG2 cells.

Key words: HepG2 cells, Stearoyl-CoA desaturase 1, Lipid synthesis

曹白鸽,刘冲霄,陈源文,董艳. IL-6上调SCD1表达对HepG2细胞脂质合成功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(2): 172-175.

Cao Baige, Liu Chongxiao, Chen Yuanwen, Dong Yan. Upregulation of SCD1 gene-related lipid synthesis by IL-6 stimulus in HepG2 cells in vitro[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 172-175.

参考文献

[1] Buzzetti E,Pinzani M,Tsochatzis EA.The multiple-hit pathogenesis of non-alcoholic fatty liver disease(NAFLD). Metabolism,2016,65(8):1038-1048.
[2] Carulli L,Canedi I,Rondinella S,et al.Genetic polymorphisms in non-alcoholic fatty liver disease:Interleukin-6174G/C polymorphism is associated with non-alcoholic steatohepatitis. Dig Liver Dis,2009,41(11):823-828.
[3] Genc H,Dogru T,Kara M,et al.Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease. Ann Hepatol,2013,12(4):548.
[4] Maurizio P,Novo E.Nrf1 gene expression in the liver:a single gene linking oxidative stress to NAFLD,NASH and hepatic tumours. J Hepatol,2005,43,1096-1097.
[5] Zhao L,Zhong S,Qu H,et al.Chronic inflammation aggravates metabolic disorders of hepatic fatty acids in high-fat diet-induced obese mice. Sci Rep,2015,5:10222.
[6] Amor AJ, Cofan M,Mateo-Gallego R,et al.Dietary polyunsaturated fatty acids mediate the inverse association of stearoyl-CoA desaturase activity with the risk of fatty liver in dyslipidaemic individuals. Eur J Nutr,2018,34(Suppl 2):1-8.
[7] Huang YH,Ye TT,Liu CX,et al.Maternal high-fat diet during pregnancy and lactation affects rat offspring’s hepatic lipid metabolism in their early life. J Biosciences,2017,42(2):311-319.
[8] Fabbrini E,Sullivan S,Klein S.Obesity and nonalcoholic fatty liver disease:biochemical,metabolic,and clinical implications. Hepatology,2010,51(2):679-689.
[9] Chalasani N,Younossi Z,Lavine JE,et al.The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Association for the Study of Liver Diseases,American College of Gastroenterology,and the American Gastroenterological Association. Hepatology,2012,55:2005-2023.
[10] Tessari P,Coracina A,Cosma A,et al.Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis,2009,19(4):291-302.
[11] Liaskou E,Wilson DV,Oo YH.Innate immune cells in liver inflammation. Mediators Inflamm,2012,2012:949157.
[12] 贾艳红,李相迁,赵彩彦. 炎症小体与非酒精性脂肪性肝炎.实用肝脏病杂志,2017,20(3):377-380.
[13] Vida M,Gavito AL,Pavón FJ,et al.Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice. Dis Model Mech,2015,8(7):721-731.
[14] Gavito AL,Cabello R,Suarez J,et al.Single administration of recombinant IL-6 restores the gene expression of lipogenic enzymes in liver of fasting IL-6-deficient mice. Bri J Pharmacol,2016,173(6):1070.

IL-6上调SCD1表达对HepG2细胞脂质合成功能的影响^*

Upregulation of SCD1 gene-related lipid synthesis by IL-6 stimulus in HepG2 cells in vitro

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 14

编辑推荐

Metrics

本文评价

[1]	张莹, 王洪岩, 迟程, 徐有青. LPS诱导的HepG2细胞NOTCH与LPS-TLR4-NF-κB炎症信号通路的“会话”研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 470-473.
[2]	王爽, 许坚吉, 刘晓霓, 陈德喜. 荧光素酶生物发光报告体系的优化及在肝癌荷瘤裸鼠模型中的应用^*[J]. 实用肝脏病杂志, 2019, 22(4): 482-485.
[3]	张小三, 张一鸣, 杨树军, 戚春辉, 刘凯, 赵燕. miR-21对HepG2细胞增殖、凋亡和细胞周期的影响^*[J]. 实用肝脏病杂志, 2019, 22(1): 21-24.
[4]	姜哲, 舒敏, 王媛媛, 朴莲淑. miR-363靶向调控E2F3表达影响HepG2细胞增殖和凋亡研究^*[J]. 实用肝脏病杂志, 2018, 21(6): 825-828.
[5]	欧志涛, 詹远京, 郭家伟, 罗铎. CIAPIN1对HepG2细胞增殖和细胞周期的影响[J]. 实用肝脏病杂志, 2018, 21(1): 38-41.
[6]	王以浪，印滇，杨莉，张亮，姚登福. 胰岛素抵抗肝癌细胞IGF-1R/NF-κB表达及多药耐药机制研究[J]. 实用肝脏病杂志, 2016, 19(6): 704-708.
[7]	丁宁, 张明香. 人HNF4α基因真核表达载体的构建与鉴定^*[J]. 实用肝脏病杂志, 2016, 19(2): 156-159.
[8]	郭灿, 曾莉. 疏肝健脾方含药血清对酒精性损伤HepG2细胞脂肪变性的保护作用[J]. 实用肝脏病杂志, 2016, 19(2): 160-163.
[9]	赵斐, 谢萍, 姜佳丽, 张令强, 安威, 展玉涛. 他莫昔芬体外促进HepG2细胞脂肪变性观察^*[J]. 实用肝脏病杂志, 2014, 17(1): 30-33.
[10]	梁慧敏, 时小燕, 和振坤, 徐庆杰. 黄芩苷诱导人肝癌HepG-2细胞凋亡作用观察[J]. 实用肝脏病杂志, 2012, 15(4): 343-345.
[11]	邓豫,王桂华,金源,李小兰,陶德定,李维娜,龚建平,胡俊波. TAT-N24穿膜融合多肽对HepG2细胞增殖的影响^*[J]. 实用肝脏病杂志, 2011, 14(5): 321-322.
[12]	熊熙,汪茂荣. 南蛇藤乙酸乙酯提取物诱导HepG2细胞凋亡的实验研究^*[J]. 实用肝脏病杂志, 2011, 14(4): 249-252.
[13]	王新红,邢慧,陈晶,范玉晶,刘丹,刘红霞,吕志武. 针对STAT3的siRNA抑制HepG2细胞增殖和p44/42MAPK蛋白的表达*[J]. 实用肝脏病杂志, 2010, 13(6): 401-403.
[14]	范熠, 唐宇, 高燕. TLR9受体介导枯否细胞对转染HepG2细胞HBx信号转导的抑制作用[J]. 实用肝脏病杂志, 2010, 13(1): 9-12.